Skip to main content
. 2021 Feb 9;2021(2):CD008013. doi: 10.1002/14651858.CD008013.pub3

Summary of findings 1. Antidepressant compared to placebo for the treatment of functional abdominal pain disorders in children and adolescents.

Antidepressant compared to placebo for the treatment of functional abdominal pain disorders in children and adolescents
Patient or population: Children and adolescents with functional abdominal pain disorder
Setting: Outpatient
Intervention: Antidepressant
Comparison: Placebo
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI) № of participants
(studies) Certainty of the evidence
(GRADE) Comments
Risk with placebo Risk with antidepressant
Treatment success Study population RR 1.17
(0.87 to 1.56) 205
(2 RCTs) ⊕⊕⊝⊝
LOWa
440 per 1000 515 per 1000
(383 to 686)
Withdrawals due to adverse events Study population RR 3.17
(0.65 to 15.33) 238
(3 RCTs) ⊕⊕⊝⊝
LOWa
17 per 1000 54 per 1000
(11 to 262)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; RR: Risk ratio;
GRADE Working Group grades of evidenceHigh certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded two levels due to significant imprecision for extremely sparse data.